Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis

BACKGROUND: With a suite of promising new RSV prophylactics on the horizon, including long-acting monoclonal antibodies and new vaccines, it is likely that one or more of these will replace the current monoclonal Palivizumab programme. However, choosing the optimal intervention programme will requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodgson, David, Pebody, Richard, Panovska-Griffiths, Jasmina, Baguelin, Marc, Atkins, Katherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672821/
https://www.ncbi.nlm.nih.gov/pubmed/33203423
http://dx.doi.org/10.1186/s12916-020-01802-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672821/
https://www.ncbi.nlm.nih.gov/pubmed/33203423
http://dx.doi.org/10.1186/s12916-020-01802-8

Ejemplares similares